Published online before print April 3, 2006, doi: 10.1161/01.HYP.0000215838.48170.0b
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;47:894.)
© 2006 American Heart Association, Inc.
Original Articles |
Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic Hypertension
From the Department of Internal Medicine (A.I., Y.K., T.T., M.S., M.H.), Keio University School of Medicine, Tokyo, Japan; Faculty of Applied Biological Sciences (F.S., T.N.), Gifu University, Gifu, Japan; Department of Pharmacology (A.N.), Kagawa University School of Medicine, Kagawa, Japan; and Department of Biochemistry (T.I.), Vanderbilt University School of Medicine, Nashville, Tenn.
Correspondence to Atsuhiro Ichihara, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. E-mail atzichi{at}sc.itc.keio.ac.jp
In contrast to proteolytic activation of inactive prorenin by cleavage of the N-terminal 43 residue peptide, we found that prorenin is activated without proteolysis by binding of the prorenin receptor to the pentameric "handle region" I11PLLKK15P. We hypothesized that such activation occurs in hypertensive rats and causes cardiac renin–angiotensin system (RAS) activation and end-organ damage. To test this hypothesis, we devised methods of specifically inhibiting nonproteolytic activation by decapeptide spanning the pentameric handle region peptide as a decoy. In stroke-prone spontaneously hypertensive rats (SHRsp) fed a high-salt diet, arterial pressure started to rise significantly with a marked increase in the cardiac prorenin receptor mRNA level at 8 weeks of age, and cardiac fibrosis had developed by 12 weeks of age. By immunohistochemistry using antibodies to the active site of the renin molecule, we demonstrated increased proteolytic or nonproteolytic activation of prorenin in the heart but not in plasma of SHRsp. Continuous subcutaneous administration of the handle region peptide completely inhibited the increased staining by antibodies to the active site of the renin molecule, indicating the increased nonproteolytic but not proteolytic activation of prorenin in the heart of SHRsp. Administration of the handle region peptide also inactivated tissue RAS without affecting circulating RAS or arterial pressure and significantly attenuated the development and progression of cardiac fibrosis. These results clearly demonstrate the significant role of nonproteolytically activated tissue prorenin in tissue RAS activation leading to cardiac fibrosis and significant inhibition of the cardiac damage produced by chronic infusion of the handle region peptide.
Key Words: angiotensin • antibodies • renin
Related Article:
Hypertension 2006 47: 824-826.
This article has been cited by other articles:
 |
|
 |
|
  A.H. J. Danser Does Prorenin Exert Angiotensin-Independent Effects In Vivo? Hypertension, December 1, 2009; 54(6): 1218 - 1220. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Peters, T. Schluter, T. Riegel, B. S. Peters, A. Beineke, U. Maschke, N. Hosten, J. J. Mullins, and R. Rettig Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1845 - H1852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nagai, A. Ichihara, D. Nakano, S. Kimura, N. Pelisch, Y. Fujisawa, H. Hitomi, N. Hosomi, H. Kiyomoto, M. Kohno, et al. Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats Exp Physiol, September 1, 2009; 94(9): 1016 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike, and S. Ishida (Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation Diabetes, July 1, 2009; 58(7): 1625 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pan, C. J. World, C. J. Kovacs, and B. C. Berk Glucose 6-Phosphate Dehydrogenase Is Regulated Through c-Src-Mediated Tyrosine Phosphorylation in Endothelial Cells Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 895 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mercure, G. Prescott, M.-J. Lacombe, D. W. Silversides, and T. L. Reudelhuber Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies Hypertension, June 1, 2009; 53(6): 1062 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Questions & Answers -- Understanding the Renin System Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 247 - 249. [PDF]
|
|
|
|
 |
|
 J. L. Wilkinson-Berka Prorenin and the (Pro)renin Receptor in Ocular Pathology Am. J. Pathol., December 1, 2008; 173(6): 1591 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike, and S. Ishida (Pro)renin Receptor Promotes Choroidal Neovascularization by Activating Its Signal Transduction and Tissue Renin-Angiotensin System Am. J. Pathol., December 1, 2008; 173(6): 1911 - 1918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W Batenburg and A. J. Danser Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 181 - 184. [PDF]
|
|
|
|
|
|
D. Susic, X. Zhou, E. D. Frohlich, H. Lippton, and M. Knight Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1117 - H1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Brown Aliskiren Circulation, August 12, 2008; 118(7): 773 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Shan, A. E. Cuadra, C. Sumners, and M. K. Raizada Characterization of a functional (pro)renin receptor in rat brain neurons Exp Physiol, May 1, 2008; 93(5): 701 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nguyen and A. H. J. Danser Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents Exp Physiol, May 1, 2008; 93(5): 557 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Campbell Critical Review of Prorenin and (Pro)renin Receptor Research Hypertension, May 1, 2008; 51(5): 1259 - 1264. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Feldt, U. Maschke, R. Dechend, F. C. Luft, and D. N. Muller The Putative (Pro)renin Receptor Blocker HRP Fails to Prevent (Pro)renin Signaling J. Am. Soc. Nephrol., April 1, 2008; 19(4): 743 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Feldt, W. W. Batenburg, I. Mazak, U. Maschke, M. Wellner, H. Kvakan, R. Dechend, A. Fiebeler, C. Burckle, A. Contrepas, et al. Prorenin and Renin-Induced Extracellular Signal-Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide Hypertension, March 1, 2008; 51(3): 682 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Muller, B. Klanke, S. Feldt, N. Cordasic, A. Hartner, R. E. Schmieder, F. C. Luft, and K. F. Hilgers (Pro)Renin Receptor Peptide Inhibitor "Handle-Region" Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats Hypertension, March 1, 2008; 51(3): 676 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bader Spotlight on Renin: The second life of the (Pro)renin receptor Journal of Renin-Angiotensin-Aldosterone System, December 1, 2007; 8(4): 205 - 208. [PDF]
|
|
|
|
 |
|
 M. J Brown Renin: friend or foe? Heart, September 1, 2007; 93(9): 1026 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Luft Renin and Its Putative Receptor Remain Enigmas J. Am. Soc. Nephrol., July 1, 2007; 18(7): 1989 - 1992. [Full Text] [PDF]
|
|
|
|
|
|
H. Takahashi, A. Ichihara, Y. Kaneshiro, K. Inomata, M. Sakoda, T. Takemitsu, A. Nishiyama, and H. Itoh Regression of Nephropathy Developed in Diabetes by (Pro)renin Receptor Blockade J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2054 - 2061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kaneshiro, A. Ichihara, M. Sakoda, T. Takemitsu, A.H.M. N. Nabi, M. N. Uddin, T. Nakagawa, A. Nishiyama, F. Suzuki, T. Inagami, et al. Slowly Progressive, Angiotensin II-Independent Glomerulosclerosis in Human (Pro)renin Receptor-Transgenic Rats J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1789 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Jan Danser, W. W. Batenburg, and J. H. M. van Esch Prorenin and the (pro)renin receptor--an update Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1288 - 1292. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, et al. Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 422 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ichihara Resolving the mysteries of the renin-angiotensin system in diabetes Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 250 - 251. [PDF]
|
|
|
|
|
|
A. Ichihara and Y. Kaneshiro Response to Cardiovascular Effects of Nonproteolytic Activation of Prorenin Hypertension, December 1, 2006; 48(6): e114 - e114. [Full Text] [PDF]
|
|
|
|
|
|
D. Susic, H. Lippton, M. Knight, and E. D. Frohlich Cardiovascular Effects of Nonproteolytic Activation of Prorenin Hypertension, December 1, 2006; 48(6): e113 - e113. [Full Text] [PDF]
|
|
|
|
|
|
C. Burckle and M. Bader Prorenin and Its Ancient Receptor Hypertension, October 1, 2006; 48(4): 549 - 551. [Full Text] [PDF]
|
|
|
|
|
|
M. J Brown Direct renin inhibition -- a new way of targeting the renin system Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2_suppl): S7 - S11. [Abstract] [PDF]
|
|
|
|
|
|
A.H. Jan Danser Prorenin: Back Into the Arena Hypertension, May 1, 2006; 47(5): 824 - 826. [Full Text] [PDF]
|
|